Tri-Ad™ 900SFC226Recalls & reported problems
Medtronic, Inc. · BAND 900SFC226 TRI-AD2.0 ADAMS TRICUSPID · Class 2 · Implant
All models of Tri-Ad (12)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 11
- Deaths reported
- 1
- Injuries reported
- 10
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 11 adverse event reports that list this exact device (DI 00763000102302), received between Dec 5, 2019 and Jan 15, 2026 — classified as 1 death, 10 injuries.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (6 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Insufficient Device Problem Information6
- Adverse Event Without Identified Device or Use Problem4
- Patient Device Interaction Problem3
- Intravalvular regurgitation1
Patient problems
- Insufficient Information4
- Non specific EKG/ECG Changes2
- Tricuspid Valve Insufficiency/ Regurgitation2
- Cardiomyopathy1
- Hemorrhage/Blood Loss/Bleeding1
- No Information1
- Stroke/CVA1
- Valvular Insufficiency/ Regurgitation1
Recent adverse event reports
The 11 most recent of 11 reports, in the reporter's own words as published by the FDA.
InjuryJan 15, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT DURING THE IMPLANT OF THIS 26MM TRICUSPID ANNULOPLASTY BAND, IT WAS EXPLANTED AND REPLACED WITH AN UNKNOWN PROD UCT. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information
MAUDE report 24078088 ↗InjuryMay 19, 2025Patient Device Interaction Problem; Patient Device Interaction Problem
IT WAS REPORTED THAT ON THE SAME DAY AS THE IMPLANT DATE OF THIS TRI-AD 2.0 TRICUSPID BAND, A PERMANENT PACEMAKER WAS IMPLANTED. THE REASON FOR THE PERMANENT PACEMAKER WAS REPORTED AS CARDIOMYOPATHY. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Cardiomyopathy
MAUDE report 22046576 ↗InjuryMar 19, 2025Patient Device Interaction Problem; Patient Device Interaction Problem
ADDITIONAL INFORMATION WAS RECEIVED THAT THE EVENT WAS FELT TO BE CARDIOEMBOLIC IN THE SETTING OF ATRIAL FIBRILLATION AND NOT RELATED TO THE VALVE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Stroke/CVA
MAUDE report 21644568 ↗InjuryMar 14, 2024Patient Device Interaction Problem; Patient Device Interaction Problem
MEDTRONIC RECEIVED INFORMATION THAT 5 DAYS POST IMPLANT OF THIS 26MM TRICUSPID ANNULOPLASTY BAND, IT WAS REPORTED THAT THE PATIENT HAD ATRIO-VENTRICULAR BLOCK (AV BLOCK) AND PREMATURE SUPRAVENTRICULAR COMPLEXES. ANTICOAGULATION MEDICATION FOR INTERNATIONAL NORMALIZED RATIO (INR) STABILIZATION AND ASPIRIN WERE GIVEN. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Non specific EKG/ECG Changes
MAUDE report 18908851 ↗InjuryFeb 15, 2024Insufficient Device Problem Information; Intravalvular regurgitation; Insufficient Device Problem Information; Intravalvular regurgitation
ADDITIONAL INFORMATION WAS RECEIVED THAT THE REASON FOR REPLACEMENT WAS SEVERE TRICUSPID REGURGITATION (TR). ADDITIONALLY A RIGHT THIGH AVASCULAR HEMATOMA WAS NOTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information; Tricuspid Valve Insufficiency/ Regurgitation
MAUDE report 18709449 ↗DeathAug 31, 2023Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION FROM A FAMILY MEMBER THAT DURING THE IMPLANT OF THIS 26MM TRICUSPID ANNULOPLASTY BAND, THE PATIENT DIED. IT WAS ALSO REPORTED THAT, "THEY TRIED TO PUT IN A VALVE HOWEVER IT NEEDED TO BE TAKEN OUT DUE TO BLEEDING. ANOTHER VALVE WAS ATTEMPTED TO BE IMPLANTED HOWEVER THE PATIENT DID NOT SURVIVE." THE CAUSE OF DEATH WAS NOT RECEIVED. THERE WAS NO EVIDENCE TO SUGGEST THAT THE ANNULOPLASTY BAND OR ITS FUNCTION CONTRIBUTED TO THE PATIENT¿S DEATH. IT IS UNKNOWN WHETHER AN AUTOPSY WAS PERFORMED.
Patient problems: Hemorrhage/Blood Loss/Bleeding
MAUDE report 17662699 ↗InjuryAug 31, 2022Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS 26MM TRICUSPID ANNULOPLASTY BAND, IT WAS EXPLANTED AND REPLACED WITH A 29MM BIOPROSTHETIC VALVE INDICATED FOR THE MITRAL POSITION. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information
MAUDE report 15326109 ↗InjuryJul 19, 2022Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION FROM A PATIENT THAT 2 YEARS AND 11 MONTHS POST IMPLANT OF THIS 26MM TRICUSPID ANNULOPLASTY BAND, IT WAS EXPLANTED AND REPLACED WITH A NON-MEDTRONIC VALVE. THE REASON FOR REPLACEMENT WAS REPORTED TO BE DUE TO A LEAK. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Valvular Insufficiency/ Regurgitation
MAUDE report 15052223 ↗InjuryOct 7, 2021Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS 26MM TRICUSPID ANNULOPLASTY BAND, IT WAS EXPLANTED AND REPLACED WITH AN UNKNOWN BIOPROSTHETIC VALVE. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information; Tricuspid Valve Insufficiency/ Regurgitation
MAUDE report 12590455 ↗InjuryJul 14, 2020Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT PROCEDURE OF A 26MM TRICUSPID ANNULOPLASTY BAND, THE BAND WAS EXPLANTED AND REPLACED WITH A 29 MM BIOPROSTHETIC MITRAL VALVE. THE REASON FOR REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Information
MAUDE report 10270961 ↗InjuryDec 5, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
MEDTRONIC RECEIVED INFORMATION THAT 4 DAYS POST IMPLANT OF THIS MITRAL BIOPROSTHETIC VALVE AND TRICUSPID ANNULOPLASTY BAND, A PERMANENT PACEMAKER WAS IMPLANTED DUE TO ATRIO-VENTRICULAR (AV) BLOCK. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Non specific EKG/ECG Changes
MAUDE report 9416350 ↗
Other RING, ANNULOPLASTY devices
- CG FUTURE™ 638BL32Medtronic, Inc. · RING, ANNULOPLASTY1 death71 reports
- PROFILE 3D® 680R28Medtronic, Inc. · RING, ANNULOPLASTY1 death67 reports
- CG FUTURE™ 638BL30Medtronic, Inc. · RING, ANNULOPLASTY1 death65 reports
- CG FUTURE™ 638RL32Medtronic, Inc. · RING, ANNULOPLASTY59 reports
- Tri-Ad™ 900SFC228Medtronic, Inc. · RING, ANNULOPLASTY4 deaths56 reports
- CG FUTURE™ 638BL34Medtronic, Inc. · RING, ANNULOPLASTY51 reports
- Contour 3D® 690R30Medtronic, Inc. · RING, ANNULOPLASTY1 death50 reports
- CG FUTURE™ 638BL28Medtronic, Inc. · RING, ANNULOPLASTY1 death47 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page